Assembly Health Appoints Kevin Offel as Chief Executive Officer

Veteran healthcare operator Kevin Offel takes the helm at Assembly Health, strengthening
the company's commitment to growth and provider success.

CHICAGO, Sept. 18, 2025 /PRNewswire/ -- Assembly Health, a leading provider of AI-enabled revenue cycle management and practice support services for healthcare organizations nationwide, announced today that Kevin Offel has been appointed chief executive officer, effective Sept. 4.

Offel succeeds Jack Fitzgibbons, who led Assembly through a period of rapid expansion and will transition to an executive advisor role with Shore Capital Partners, Assembly Health's investment partner. Fitzgibbons will remain closely involved to ensure a smooth leadership transition.

"Jack's leadership laid the foundation for Assembly's growth and success, and we are profoundly thankful for the vision and dedication he brought to the company," said Chris Mioton, chairman of the board at Assembly Health and partner at Shore Capital Partners. "Looking ahead, we are excited to welcome Kevin as CEO. He is a proven operator with a history of driving growth and cultivating high-performing teams. Kevin's combination of strategic insight, healthcare expertise, and servant leadership makes him the ideal person to lead Assembly into its next stage of growth and success."

Offel brings more than 25 years of healthcare leadership experience, with a career spanning both large-scale and middle-market enterprises. He has led multiple private equity–backed companies as CEO or president, including Great Lakes Dental Partners, Centennial Hospice, Heart to Heart Hospice and My Dentist.

He began his civilian career at GE Power Systems in the Junior Officer Leadership Program, where he completed leadership training at Crotonville and earned Six Sigma Black Belt certification. A fourth-generation veteran, Offel served as a U.S. Army Blackhawk helicopter pilot after graduating from the United States Military Academy at West Point. He later earned his MBA from Emory University's Goizueta Business School.

"I am honored to lead Assembly Health at such an important time in its evolution," said Kevin Offel, chief executive officer at Assembly Health. "Assembly has established a strong foundation, and I am confident we can build on that momentum to accelerate growth, deliver even greater value to providers, and strengthen our position as the leader in revenue cycle management."

Beyond his executive career, Offel served as a Civilian Aide to the Secretary of the Army (Oklahoma), a commissioner for the Oklahoma Department of Veterans Affairs and is a member of the Young Presidents' Organization. He also sits on the Board of Advisors for Emory University's Master of Business for Veterans program.

About Assembly Health

Assembly Health is a leading national provider of AI-enabled revenue cycle management (RCM) services, with more than 1,600 employees supporting over 3,000 physician groups, more than 500 long-term care communities, and behavioral health centers across the United States. Assembly's flexible RCM platform integrates seamlessly with any electronic health record or billing system, empowering providers to maintain control while improving financial performance. By embedding advanced machine learning and artificial intelligence into its platform, Assembly consistently drives operational efficiency and delivers an average 10% increase in net collections for its clients. For more information, visit www.assembly.health. 

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is an investor in lower middle market companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore's strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020-2024, Shore received recognition from Inc Magazine as a 5x Top Founder Friendly Investor and by Pitchbook Research for leading U.S. Private Equity deal volume for the past 10 years, from 2015-2024. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has approximately $13 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. To learn more about Shore Capital Partners, please visit www.shorecp.com.

Media Contact:

Lauren Zajac

[email protected] 

SOURCE Assembly Health